Clinical Trial Update: Epicardial Adipose Tissue-Targeted DApagliflozin for Reducing Electrical Remodeling in Atrial Fibrillation [NA]

View source ↗

Summary

A clinical trial is evaluating epicardial adipose tissue-targeted dapagliflozin to reduce electrical remodeling in atrial fibrillation, with the study not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Atrial Fibrillation (AF) | NA | Status: NOT_YET_RECRUITING